Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Market outline • ROA PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Pipeline landscape PART 07: Market segmentation by molecule type • Biologics • Small molecules PART 08: Geographical segmentation • Injectable drugs market in Americas • Injectable drugs market in EMEA • Injectable drugs market in APAC PART 09: Decision framework PART 10: Drivers and challenges • Market drivers • Market challenges PART 11: Market trends • Rising awareness leading to high demand for injectable drugs • Increase in industry-academia collaboration • Expected entry of novel vaccines • Advent of biosimilars PART 12: Vendor landscape • Competitive landscape PART 13: Key vendor analysis • AbbVie • F. Hoffmann-La Roche • GlaxoSmithKline • Sanofi • Other prominent vendors PART 14: Appendix • List of abbreviations List of Exhibits Exhibit 01: Market scenario: Global injectable drugs market 2016 Exhibit 02: Decisive factors for the choice of ROA Exhibit 03: Major ROA for drugs intake Exhibit 04: Types of injections Exhibit 05: Adverse effects of injectable drugs Exhibit 06: Global injectable drugs market snapshot Exhibit 07: Global injectable drugs market 2016-2021 ($ billions) Exhibit 08: Opportunity analysis in global injectable drugs market Exhibit 09: Five forces analysis Exhibit 10: Pipeline molecules by key vendors (Phase III) Exhibit 11: Key clinical trials of key vendors (Phase III) Exhibit 12: Global injectable drugs market segmentation by molecule type Exhibit 13: Global injectable drugs market segmentation by molecule type 2016 and 2021 (%) Exhibit 14: Global biologics injectable drugs market 2016-2021 ($ billions) Exhibit 15: Top biologic drugs in the injectable drugs market Exhibit 16: Global small molecules injectable drugs market 2016-2021 ($ billions) Exhibit 17: Segmentation of global injectable drugs market based on geography 2016 and 2021 (%) Exhibit 18: Global injectable drugs market by geography 2016-2021 ($ billions) Exhibit 19: Market scenario in Americas Exhibit 20: Injectable drugs market in Americas 2016-2021 ($ billions) Exhibit 21: Market scenario in EMEA Exhibit 22: Injectable drugs market in EMEA 2016-2021 ($ billions) Exhibit 23: Market scenario in APAC Exhibit 24: Injectable drugs market in APAC 2016-2021 ($ billions) Exhibit 25: Major indications finding huge applications of injectable drugs Exhibit 26: Major reasons to use injectable drugs Exhibit 27: New cases of diabetes by 2040 Exhibit 28: Major complications involved with the injections Exhibit 29: Major causes of drug shortage Exhibit 30: Competitive structure analysis of global injectable drugs market Exhibit 31: AbbVie: Key highlights Exhibit 32: AbbVie: Strength assessment Exhibit 33: AbbVie: Strategy assessment Exhibit 34: AbbVie: Opportunity assessment Exhibit 35: F. Hoffmann-La Roche: Key highlights Exhibit 36: F. Hoffmann-La Roche: Strength assessment Exhibit 37: F. Hoffmann-La Roche: Strategy assessment Exhibit 38: F. Hoffmann-La Roche: Opportunity assessment Exhibit 39: GlaxoSmithKline: Key highlights Exhibit 40: GlaxoSmithKline: Strength assessment Exhibit 41: GlaxoSmithKline: Strategy assessment Exhibit 42: GlaxoSmithKline: Opportunity assessment Exhibit 43: Sanofi: Key highlights Exhibit 44: Sanofi: Strength assessment Exhibit 45: Sanofi: Strategy assessment Exhibit 46: Sanofi: Opportunity assessment

AbbVie, F. Hoffmann-La Roche, GlaxoSmithKline, Sanofi, Bayer, Bristol-Myers Squibb, Merck, Takeda Pharmaceutical, and Teva Pharmaceutical.